Has Mohammad Alqarqaz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,188 in general payments to Mohammad Alqarqaz, MD across 35 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mohammad Alqarqaz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mohammad Alqarqaz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mohammad Alqarqaz, MD

Cardiovascular Disease · Detroit, MINPI 1104073766

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,000 of the $6,188 with a category attached, or 64.6%. Abiomed accounts for 69.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $4,569 and has fallen 89.7% since, to $469 in 2025.

$6,188in general payments, 2019–2025

Across 35 payments — averaging $176.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$4K
Boston Scientific$660
Inari Medical, Inc.$450
Philips North America LLC$170
Abbott$137
Stryker$117
plus $369 from 5 others

$59,872in research payments, 2019–2025

Across 11 payments — averaging $5442.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arrow International, Inc.$60K

What the payments were for

Speaking & faculty fees$4,00065%
Food & beverage$2,18835%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	5	$4,285
Boston Scientific	8	$660
Inari Medical, Inc.	4	$450
Philips North America LLC	3	$170
Abbott	6	$137
Stryker	1	$117
Biosense Webster, Inc.	1	$110
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$105
Chiesi USA, Inc.	2	$88
Verge Medical, Inc.	2	$53
Siemens Medical Solutions USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,188 in reported general payments places this provider in the 65th percentile of 760 cardiovascular disease providers in Michigan.

See all cardiovascular disease providers in Michigan →

Medicare billing

Part B allowed, 2024

$77,502

Medicare patients

151

Services billed

478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	91	$106,882
BrilintaTicagrelor	12	$12,973
Atorvastatin Calcium	180	$3,243
Rosuvastatin Calcium	79	$2,244
Metoprolol Succinate	113	$2,091
ClopidogrelClopidogrel Bisulfate	89	$1,271
Carvedilol	69	$975
Losartan Potassium	67	$827
Isosorbide Mononitrate ErIsosorbide Mononitrate	32	$816
Amlodipine Besylate	71	$791
Ezetimibe	22	$437
Metoprolol Tartrate	38	$435
Lisinopril	36	$381
Nifedipine ErNifedipine	13	$349
Warfarin Sodium	18	$261

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Detroit

Pedro Villablanca SpinettoDetroit$620K
Wayne WeaverDetroit$340K
Brian OneillDetroit$250K
Karthikeyan AnanthasubramaniamDetroit$112K
Gerald KoenigDetroit$96K
David LanfearDetroit$82K
Celeste WilliamsDetroit$70K
Mahir ElderDetroit$68K
Cori RussellDetroit$67K
Pedro Engel GonzalezDetroit$66K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →